David A. Bristol
Direktor/Vorstandsmitglied bei HCF Enterprises, Inc.
Aktive Positionen von David A. Bristol
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HCF Enterprises, Inc. | Direktor/Vorstandsmitglied | - | - |
| Sentinel Private Equity XVI Fund | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von David A. Bristol
Ehemalige bekannte Positionen von David A. Bristol
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Exxon Co. USA | Corporate Officer/Principal | 02.01.1991 | 02.01.1991 |
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | 28.07.2011 | - |
Ausbildung von David A. Bristol
| Brown University | Undergraduate Degree |
| The University of Texas at Austin | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
| HCF Enterprises, Inc. | |
| Exxon Co. USA | |
| Sentinel Private Equity XVI Fund |
- Börse
- Insiders
- David A. Bristol
- Erfahrung
